n-(1-methyl-2-phenylethyl)adenosine has been researched along with 11-cis-retinal in 1 studies
| Studies (n-(1-methyl-2-phenylethyl)adenosine) | Trials (n-(1-methyl-2-phenylethyl)adenosine) | Recent Studies (post-2010) (n-(1-methyl-2-phenylethyl)adenosine) | Studies (11-cis-retinal) | Trials (11-cis-retinal) | Recent Studies (post-2010) (11-cis-retinal) |
|---|---|---|---|---|---|
| 134 | 0 | 4 | 7,289 | 4 | 2,014 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dice, A; Dineen, B; Dunwiddie, TV; Gilchrist, A; Hamm, HE; Linden, J; Lupica, CR; Mazzoni, MR; Proctor, WR | 1 |
1 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and 11-cis-retinal
| Article | Year |
|---|---|
Antagonists of the receptor-G protein interface block Gi-coupled signal transduction.
Topics: Adenosine; Animals; Baclofen; Binding, Competitive; Brain; Cells, Cultured; Electrophysiology; GTP-Binding Proteins; Humans; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, Purinergic P1; Rhodopsin; Signal Transduction; Xanthines | 1998 |